Genta Will Appeal FDA “Not Approvable” Action On Genasense
Company highlights supporting statements from medical experts in quest to overcome FDA’s position on valid CLL endpoints.
Company highlights supporting statements from medical experts in quest to overcome FDA’s position on valid CLL endpoints.